Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    New Phase 1/2 CPI-0610 study with and without ruxolitinib added, broader MF/MPN trial scope, expanded criteria and sites, plus IPD data-sharing plan. Previous MF-only Phase 2 study and several location listings were removed.
    Difference
    100%
    Check dated 2025-10-13T02:24:17.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Key changes: added a broad operating-status notice and an updated version tag (v3.2.0); removed the specific medical term ‘Essential thrombocythemia’ and the older version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T14:25:35.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T09:45:06.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    No significant changes detected.
    Difference
    0.3%
    Check dated 2025-09-21T06:36:05.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to Revision: v3.0.2, replacing v3.0.1, indicating an update to the content. The Back to Top element was removed, a minor UI change.
    Difference
    0.4%
    Check dated 2025-09-14T00:17:48.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.4%
    Check dated 2025-09-06T21:13:31.000Z thumbnail image

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.